[go: up one dir, main page]

TWI369183B - Compositions and methods of formulation for enteral formulas containing sialic acid - Google Patents

Compositions and methods of formulation for enteral formulas containing sialic acid

Info

Publication number
TWI369183B
TWI369183B TW093109749A TW93109749A TWI369183B TW I369183 B TWI369183 B TW I369183B TW 093109749 A TW093109749 A TW 093109749A TW 93109749 A TW93109749 A TW 93109749A TW I369183 B TWI369183 B TW I369183B
Authority
TW
Taiwan
Prior art keywords
formulation
compositions
methods
sialic acid
formulas containing
Prior art date
Application number
TW093109749A
Other languages
English (en)
Other versions
TW200503631A (en
Inventor
Robert J Mcmahon
Mary Frances Locniskar
Steven Charles Rumsey
Joshua C Anthony
Ratchapong Wungtanagorn
Original Assignee
Mead Johnson Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson Nutrition Co filed Critical Mead Johnson Nutrition Co
Publication of TW200503631A publication Critical patent/TW200503631A/zh
Application granted granted Critical
Publication of TWI369183B publication Critical patent/TWI369183B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
TW093109749A 2003-04-14 2004-04-08 Compositions and methods of formulation for enteral formulas containing sialic acid TWI369183B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/413,508 US7867541B2 (en) 2003-04-14 2003-04-14 Compositions and methods of formulation for enteral formulas containing sialic acid

Publications (2)

Publication Number Publication Date
TW200503631A TW200503631A (en) 2005-02-01
TWI369183B true TWI369183B (en) 2012-08-01

Family

ID=33131416

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093109749A TWI369183B (en) 2003-04-14 2004-04-08 Compositions and methods of formulation for enteral formulas containing sialic acid

Country Status (21)

Country Link
US (1) US7867541B2 (zh)
EP (1) EP1613169B1 (zh)
KR (1) KR101087332B1 (zh)
CN (1) CN100515216C (zh)
AR (1) AR043846A1 (zh)
AT (1) ATE469560T1 (zh)
BR (1) BRPI0409309B1 (zh)
CA (1) CA2522091C (zh)
CL (1) CL2004000803A1 (zh)
DE (1) DE602004027476D1 (zh)
DK (1) DK1613169T3 (zh)
EC (1) ECSP056101A (zh)
ES (1) ES2346533T3 (zh)
MX (1) MXPA05010806A (zh)
MY (1) MY154371A (zh)
NO (1) NO330441B1 (zh)
PL (1) PL1613169T3 (zh)
PT (1) PT1613169E (zh)
RU (1) RU2361408C2 (zh)
TW (1) TWI369183B (zh)
WO (1) WO2004093557A1 (zh)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0951842B1 (en) * 1999-01-20 2002-12-04 N.V. Nutricia Infant formula
EP1342071A1 (fr) * 2000-12-13 2003-09-10 Institut d'Optique Theorique et appliquee Procede de caracterisation d'une surface, et dispositif pour sa mise en oeuvre
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US7951410B2 (en) * 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
ES2587338T3 (es) * 2004-10-12 2016-10-24 Fonterra Co-Operative Group Limited Productos lácteos de beta-suero, productos lácteos con depleción de lípidos neutros y/o enriquecidos en lípidos polares y procesos para su producción
US20060246146A1 (en) * 2005-04-29 2006-11-02 Mcmahon Robert J Method of increasing the salivary sialic acid content in a mammal
US20060247153A1 (en) * 2005-04-29 2006-11-02 Mcmahon Robert J Method of improving learning and memory in mammals
PT1888081T (pt) 2005-05-23 2017-03-01 Massachusetts Inst Technology Composições contendo pufa e seus métodos de utilização
BRPI0616323A2 (pt) 2005-09-20 2011-06-14 Prolacta Bioscience Inc mÉtodo para determinar se um fluido mamÁrio doado foi obtido a partir de um indivÍduo especÍfico
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
CA2628225C (en) * 2005-11-04 2014-06-17 Hans Henrik Holst A concentrate derived from a milk product enriched in naturally occurring sialyllactose and a process for preparation thereof
ES2584191T3 (es) * 2005-11-30 2016-09-26 Vegenat, S.A. Mezcla de proteínas y su utilización para preparar un producto destinado a la alimentación oral o enteral
PL1800675T4 (pl) * 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
US20080003330A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
DK2099321T3 (en) * 2006-11-29 2017-07-17 Prolacta Bioscience Inc Human milk compositions and methods for their preparation and use
CA2706723C (en) * 2006-12-08 2015-05-19 Prolacta Bioscience, Inc. Compositions of human lipids and methods of making and using same
AU2008267279B2 (en) * 2007-06-25 2014-02-27 Dsm Ip Assets B.V. Novel prebiotics
ATE536105T1 (de) * 2007-09-17 2011-12-15 Nutricia Nv Ernährungsformulierung mit hohem energetischen gehalt
AU2008312069B2 (en) * 2007-10-19 2014-03-06 Fonterra Co-Operative Group Limited Methods of maintaining or increasing growth or cognitive development
EP2096115A1 (en) * 2008-02-26 2009-09-02 Nestec S.A. Oligosaccharide ingredient
KR101116864B1 (ko) * 2008-08-01 2012-02-29 주식회사 베네비오 고지혈증, 지방간 또는 비만의 예방 또는 치료용 조성물
ATE538667T1 (de) 2008-11-10 2012-01-15 Nestec Sa Sialsäure produzierende bakterien
CN102300575A (zh) 2008-12-02 2011-12-28 普罗莱克塔生物科学公司 人乳渗透物组合物及其制备和使用方法
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
KR101158472B1 (ko) * 2009-11-05 2012-06-20 주식회사 베네비오 알코올에 유발된 간질환의 예방 또는 치료용 조성물
CA2792112C (en) * 2010-03-12 2018-09-04 Dsm Ip Assets B.V. Maternal sialic acid supplementation
EP2554057A4 (en) * 2010-03-31 2013-12-18 Vegenat S A ENERAL OR ORAL FOOD PRODUCT SPECIALLY FOR NUTRITION, PREVENTION AND MITIGATION OF NEUROLOGICAL OR NEURODEGENERATIVE ALTERATIONS OR COGNITIVE DISORDERS
EP2554058A4 (en) * 2010-03-31 2013-12-25 Vegenat S A FUNCTIONAL FOOD SUPPLEMENT, IN PARTICULAR FOR NUTRITIONAL AND PREVENTION AND IMPROVEMENT OF NEUROLOGICAL ILLNESSES, NEURODEEGENERATIVE ILLNESSES OR COGNITIVE DISORDERS
WO2012092159A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
CN110051676A (zh) 2010-12-31 2019-07-26 雅培制药有限公司 用于调节炎症的人乳寡糖
ES2708924T3 (es) 2010-12-31 2019-04-12 Abbott Lab Procedimientos de uso de oligosacáridos de la leche humana para mejorar la salud respiratoria de las vías respiratorias
SG10202110501RA (en) 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
EP3510873A1 (en) 2010-12-31 2019-07-17 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
NZ612455A (en) 2010-12-31 2015-02-27 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
BR112013016587A2 (pt) 2010-12-31 2016-09-27 Abbott Lab formulações nutricionais incluindo oligossacarídeos de leite humano e antioxidantes e usos das mesmas
PH12013501501A1 (en) 2011-02-10 2019-10-07 Nestec Sa Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
BR112013033565B1 (pt) 2011-06-30 2021-06-29 Chr. Hansen A/S Composição seca, pó para recém-nascido, fórmula, leite, produto alimentício ou suplemento dietético
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
BR112014001472A2 (pt) 2011-07-22 2017-02-21 Abbott Lab galactooligossacarídeos para prevenir lesões e / ou promover a cicatrização do trato gastrointestinal
DK2739157T3 (en) 2011-08-03 2018-01-08 Prolacta Bioscience Inc Microfiltration of human milk to reduce bacterial contamination
BR112014004772A2 (pt) 2011-08-29 2017-03-21 Abbott Lab oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US20140179782A1 (en) * 2011-10-14 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
RU2620370C2 (ru) 2011-12-14 2017-05-25 Нестек С.А. Эмульгированный пищевой продукт, содержащий молочный белок
US20140179775A1 (en) * 2012-02-29 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
US9351978B2 (en) * 2012-02-29 2016-05-31 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
CN104427887A (zh) * 2012-03-14 2015-03-18 雅培制药有限公司 包含RRR-α生育酚和多不饱和脂肪酸的营养组合物
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
US9844532B2 (en) 2013-03-13 2017-12-19 Abbott Laboratories Infant nutritional product with RRR alpha-tocopherol
CA2901457C (en) 2013-03-13 2018-07-31 Abbott Laboratories A composition for enhancing newborn infant cognitive, brain and/or cns development and method of using same
PT2967094T (pt) 2013-03-13 2021-01-14 Prolacta Bioscience Inc Produtos de leite humano com elevado teor de matéria gorda
CN103478251B (zh) * 2013-07-23 2015-03-25 东北农业大学 一种含唾液酸婴儿配方奶粉的制备方法
CN104187742A (zh) * 2014-07-09 2014-12-10 上海育生堂科技有限公司 一种用于促进青少年儿童成长和改善大脑发育的食用组合物
RU2761533C2 (ru) 2014-09-25 2021-12-09 Сосьете Де Продюи Нестле С.А. Система детской смеси с адаптивными концентрациями олигосахаридов грудного молока (огм)
WO2016145628A1 (en) * 2015-03-18 2016-09-22 Nestec S.A. Composition comprising siallyllactose for use in enhancing learning skills and memory function
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US20170006897A1 (en) 2015-07-10 2017-01-12 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
US11478011B2 (en) * 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
IL303044B2 (en) 2015-12-30 2025-05-01 Prolacta Bioscience Inc Human milk products used before and after active treatment
CN106615146A (zh) * 2016-09-01 2017-05-10 西安银桥乳业（集团）有限公司 一种添加组合益生元的婴幼儿配方奶粉及其制备方法
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
CN107467667B (zh) * 2017-07-17 2018-06-26 北京亦贝安生物医药科技有限公司 一种含有两种不饱和脂肪酸和唾液酸的复方制剂
EP3473644A1 (en) 2017-10-17 2019-04-24 Jennewein Biotechnologie GmbH Fermentative production of n-acetylneuraminic acid
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
GB2573538B (en) 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section
MX2022002949A (es) 2019-09-24 2022-04-06 Prolacta Bioscience Inc Composiciones y metodos para el tratamiento de enfermedades inflamatorias e inmunes.
CN111011522A (zh) * 2020-02-27 2020-04-17 青岛索康食品有限公司 一种提高免疫力的儿童配方奶粉及其制备方法
CN113068747A (zh) * 2020-03-24 2021-07-06 北京三元食品股份有限公司 一种促进孕产妇和婴幼儿健康的孕产妇配方乳粉

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762822A (en) 1985-08-08 1988-08-09 Ettinger Anna C Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides
DD273543A3 (de) 1987-09-14 1989-11-22 Univ Rostock Verfahren zur herstellung von saeuglings- und diaetnahrungen mit hypoantigener, bifidogener wirkung
ES2053627T3 (es) 1988-07-07 1994-08-01 Milupa Ag Procedimiento para la preparacion de un alimento bifidogeno dietetico y para lactantes.
US6020015A (en) 1988-09-22 2000-02-01 Gaull; Gerald E. Infant formula compositions and nutrition containing genetically engineered human milk proteins
EP0481038B1 (en) 1990-04-16 2002-10-02 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
CH681543A5 (zh) * 1990-04-27 1993-04-15 Nestle Sa
JP3035833B2 (ja) 1991-01-21 2000-04-24 雪印乳業株式会社 シアル酸類含有組成物の製造方法
JP3125451B2 (ja) * 1991-11-05 2001-01-15 ソニー株式会社 信号処理方法
JPH07277929A (ja) 1994-04-01 1995-10-24 Momotani Jiyuntenkan:Kk 育毛、養毛料
US5576300A (en) 1994-09-16 1996-11-19 Abbott Laboratories Method for inhibition of human rotavirus infection
US5575916A (en) 1994-11-07 1996-11-19 Neose Pharmaceuticals, Inc. Method of processing a cheese processing waste stream
US5849324A (en) 1995-07-10 1998-12-15 Abbott Laboratories Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
KR20000035798A (ko) 1996-08-30 2000-06-26 뷜르 로망 엘. 페닐케톤뇨증 환자용 영양 처방식
EP0893064B1 (fr) * 1997-07-22 2003-01-15 Societe Des Produits Nestle S.A. Composition lipidique pour formule infantile et procédé de préparation
US6168823B1 (en) 1997-10-09 2001-01-02 Wisconsin Alumni Research Foundation Production of substantially pure kappa casein macropeptide
EP1048226B1 (en) 1999-04-29 2005-08-31 Société des Produits Nestlé S.A. Infant formula containing sweet whey protein
US6288222B1 (en) 2000-02-16 2001-09-11 Neose Technologies, Inc. Method of filtration of a dairy stream
BRPI0108478B8 (pt) 2000-02-17 2021-05-25 Nestec Sa composição nutritiva contendo substancias pré-bióticas
US20020044988A1 (en) 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
GB0116509D0 (en) 2001-07-06 2001-08-29 Hannah Res Inst The Methods of extracting casein fractions from milk and caseinates and production of novel products

Also Published As

Publication number Publication date
AR043846A1 (es) 2005-08-17
ECSP056101A (es) 2006-03-01
HK1091376A1 (zh) 2007-01-19
EP1613169B1 (en) 2010-06-02
BRPI0409309B1 (pt) 2020-09-15
TW200503631A (en) 2005-02-01
PT1613169E (pt) 2010-06-17
KR101087332B1 (ko) 2011-11-25
EP1613169A1 (en) 2006-01-11
CL2004000803A1 (es) 2005-05-06
US7867541B2 (en) 2011-01-11
DE602004027476D1 (de) 2010-07-15
CA2522091C (en) 2011-10-11
DK1613169T3 (da) 2010-09-20
MY154371A (en) 2015-06-15
MXPA05010806A (es) 2005-12-05
ES2346533T3 (es) 2010-10-18
KR20060006921A (ko) 2006-01-20
RU2361408C2 (ru) 2009-07-20
BRPI0409309A (pt) 2006-04-18
RU2005135122A (ru) 2006-03-10
NO20055335L (no) 2006-01-03
PL1613169T3 (pl) 2010-11-30
NO330441B1 (no) 2011-04-11
CA2522091A1 (en) 2004-11-04
NO20055335D0 (no) 2005-11-11
US20040202765A1 (en) 2004-10-14
CN100515216C (zh) 2009-07-22
WO2004093557A1 (en) 2004-11-04
CN1802094A (zh) 2006-07-12
ATE469560T1 (de) 2010-06-15

Similar Documents

Publication Publication Date Title
TWI369183B (en) Compositions and methods of formulation for enteral formulas containing sialic acid
PL1811868T3 (pl) Kompozycje i sposoby formułowania mieszanek dojelitowych zawierających kwas sialowy
EP1610742A4 (en) METHODS AND COMPOSITIONS FOR ADMINISTERING TRPV1 AGONISTS
IL166108A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
IL173930A0 (en) Pharmaceutical compositions containing forms of r-baclofen
PL2181988T3 (pl) Kompozycje farmaceutyczne oparte na Krystalicznej Postaci I 5-azacytydyny
HUP0500173A3 (en) Alpha-sulphonamido-acetamide derivatives as beta-amyloid inhibitors and pharmaceutical compositions containing them
IL172776A (en) Derivatives of esters of 3-oxo-10 ß-hydroxy-17 ß-cyanomethyl (oxo / theo) carbonyl – androsta – 4,1 – dian – 17 α– carboxylic acid and pharmaceutical preparations containing them
IL179250A0 (en) Stable crystal of 4-oxoquinoline compound and pharmaceutical compositions containing the same
AU2003251557A1 (en) Fat compositions for infant formula and methods therefor
IL164217A0 (en) Pharmaceutical compositions containing water-soluble propofol and methods of administering same
HUP0401693A3 (en) Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, their preparation an use and pharmaceutical compositions containing such derivatives
PL1601363T3 (pl) Zastosowanie pochodnych cholest-4-en-onu jako leków, kompozycje farmaceutyczne zawierające te pochodne, nowe pochodne i sposób ich wytwarzania
IL166054A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
IL163959A (en) Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them
IL170316A (en) Cycloalkyl-methoxy substituted acetic acid derivatives and pharmaceutical compositions comprising them
ZA200602840B (en) Pharmaceutical compositions comprising malonamide derivatives for decreasing sebum production
ZA200600315B (en) Compositions for purifying and crystallizing molecules of interest
IL174248A0 (en) Alkyl carboxylic acid derivatives and pharmaceutical compositions containing the same
IL176077A0 (en) 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
EG24668A (en) Cyclic amine derivatives processes for their preparation and pharmaceutical compositions containing them
IL157849A0 (en) Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives
IL172758A0 (en) Pharmaceutical compositions containing balaglitazone and methods for the preparation thereof
IL169312A0 (en) Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
GB2404856B (en) Stable pharmaceutical composition of rabeprazole

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees